vancomycin has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duanmu, N; Fu, L; Huang, X; Wang, N | 1 |
| Bhattacharya, J; Bhattacharya, S; Hook, JL; Islam, MN; Parker, D; Prince, AS | 1 |
2 other study(ies) available for vancomycin and Chronic Lung Injury
| Article | Year |
|---|---|
Early Warning and Clinical Epidemiological Characteristics of Lung Injury in the Treatment of Infectious
Topics: Algorithms; Humans; Lung; Lung Injury; Sepsis; Staphylococcus aureus; Vancomycin | 2022 |
Disruption of staphylococcal aggregation protects against lethal lung injury.
Topics: Animals; Anti-Bacterial Agents; Calcium; Cytosol; Gap Junctions; Hemolysin Proteins; Humans; Lung; Lung Injury; Male; Mice; Mice, Inbred C57BL; Perfusion; Pulmonary Alveoli; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2018 |